Wikidata entity: Q384295
C₁₅H₂₂O₃ (P274)
Quantities
| P4250 | defined daily dose | 1.2 |
| P2067 | mass | 250.157 |
| P3780 | active ingredient in | ... | Q47521782 (Lopid) | Lopid |
| P233 | canonical SMILES | String | CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O | ??? |
| P373 | Commons category | String | Gemfibrozil | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284310 (LiverTox toxicity likelihood category C) | LiverTox toxicity likelihood category C |
| P2175 | medical condition treated | ... | Q184559 (arteriosclerosis) | arteriosclerosis |
| P2175 | medical condition treated | ... | Q844935 (coronary artery disease) | coronary artery disease |
| P2175 | medical condition treated | ... | Q1467339 (hypertriglyceridemia) | hypertriglyceridemia |
| P2175 | medical condition treated | ... | Q18554145 (familial hyperlipidemia) | familial hyperlipidemia |
| P129 | physically interacts with | ... | Q7169506 (Peroxisome proliferator activated receptor alpha) | Peroxisome proliferator activated receptor alpha |
| P129 | physically interacts with | ... | Q21125248 (solute carrier organic anion transporter family member 1B3) | solute carrier organic anion transporter family member 1B3 |
| P129 | physically interacts with | ... | Q21125253 (Solute carrier organic anion transporter family member 1B1) | Solute carrier organic anion transporter family member 1B1 |
| P129 | physically interacts with | ... | Q21136123 (Solute carrier organic anion transporter family member 2B1) | Solute carrier organic anion transporter family member 2B1 |
| P769 | significant drug interaction | ... | Q326224 ((S)-(−)-colchicine) | (S)-(−)-colchicine |
| P769 | significant drug interaction | ... | Q415159 (rosuvastatin) | rosuvastatin |
| P769 | significant drug interaction | ... | Q417942 (fluvastatin) | fluvastatin |
| P769 | significant drug interaction | ... | Q668093 (atorvastatin) | atorvastatin |
| P769 | significant drug interaction | ... | Q670131 (simvastatin) | simvastatin |
| P769 | significant drug interaction | ... | Q1240093 (pravastatin) | pravastatin |
| P769 | significant drug interaction | ... | Q113368879 (rac-warfarin) | rac-warfarin |
| P769 | significant drug interaction | ... | Q1996756 (enzalutamide) | enzalutamide |
| P279 | subclass of | ... | Q134856 (carboxylic acid) | carboxylic acid |
| P279 | subclass of | ... | Q43305851 (phenol ether) | phenol ether |
| P2868 | subject has role | ... | Q187661 (carcinogen) | carcinogen |
| P2868 | subject has role | ... | Q955332 (hypolipidemic) | hypolipidemic |
| P2868 | subject has role | ... | Q50430505 (cytochrome P-450 CYP2C8 inhibitors) | cytochrome P-450 CYP2C8 inhibitors |
| P2868 | subject has role | ... | Q55427774 (male reproductive toxicant) | male reproductive toxicant |
| P2868 | subject has role | ... | Q55427776 (female reproductive toxicant) | female reproductive toxicant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | gemfibrozil | ??? |
Why not click here or view trends?
log id: 2494011